Meridian Bioscience falls after swinging to loss in Q3
05/08/2022 14:02
** Shares of diagnostic products maker Meridian Bioscience
VIVO.O down ~2% at $31.08 in light premarket vols
** Co swings to a loss in Q3, reports 16 cents/shr loss vs
26 cents/shr profit a year earlier urn:newsml:reuters.com:*:nPn980wBXa
** Revenue from life sciences segment plunged 22% from last
year, when strong demand for COVID-19 testing helped the unit -
VIVO
** Excluding items, costs jumped 13% in the quarter
** As of last close, VIVO stock had jumped 55% YTD
(Reporting by Niket Nishant in Bengaluru)
((Niket.Nishant@thomsonreuters.com;))
Recent news on VivoPower
See all newsBrief: Vivopower Signs Definitive Heads Of Agreement With Open Innovation Ai To Develop Secure Sovereign Ai Data Centers Across The Nordics, Mainland Europe, The GCC And Selective Countries In Asia
Brief: Vivopower Approves Independent Listing Of 2.2Gw Non-Nordic Ai Infrastructure Platform, Transferring Capital Expenditure Requirements Whilst Retaining De Facto Control
Brief: Vivopower Secures Us$50 Million Pipe At Us$7.50 Conversion Price Per Share
Brief: Vivopower Shortlists Ai Tenants For 41.5Mw Norway Ai Data Center After Receiving Multiple Bids
Brief: Vivopower PLC Prequalifies 30 MW From Mo I Rana Data Center Into Statnett Reserve Markets